CRT-101 No Closure on Publicly Reported Adverse Events with Vascular Closure Devices

The use of vascular closure devices (VCDs) following transfemoral procedures reduces recovery time and may reduce bleeding. Transradial (TR) access is associated with fewer adverse events (AEs). The frequency of real-world AEs with VCDs and the effect of increasing TR access are unknown. The FDA